Sign in
PRTG Stock Price, Chart, Stats & News
Portage Biotech Inc.
Save
15.52M
Market cap
–
Current P/E
–
Forward P/E
PRTG chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -0.10% |
ROA | -229.71% |
ROE | -1330.99% |
D/E | – |
Interest coverage ratio | – |
PRTG valuation
P/E | – |
P/S | – |
P/B | -72.14x |
P/CF | -2.35x |
P/FCF | -4.11x |
P/OCF | -2.35x |
PEG | 0.53x |
EV multiple | -3.78x |
About
Portage Biotech Inc., operating through its various subsidiaries, focuses on the discovery and advancement of novel pharmaceutical and biotechnological products. The company's extensive pipeline includes several key therapeutic candidates and platforms. Among these are IMM60, an activator for iNKT cells; IMM65, a specialized PLGA-nanoparticle integrated with a NY-ESO-1 peptide vaccine; and INT230-6, which is currently in Phase I/II clinical trials for addressing solid tumors.
Similar securities
Based on sector and market capitalization
Report issue